These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 8843162
1. A molecular model for human Big-Endothelin-1 (Big ET-1). Peto H, Corder R, Janes RW, Wallace BA. FEBS Lett; 1996 Sep 30; 394(2):191-5. PubMed ID: 8843162 [Abstract] [Full Text] [Related]
2. Disulfide bonds in big ET-1 are essential for the specific cleavage at the Trp(21)-Val(22) bond by soluble endothelin converting enzyme-1 from baculovirus/insect cells. Fahnoe DC, Johnson GD, Herman SB, Ahn K. Arch Biochem Biophys; 2000 Jan 15; 373(2):385-93. PubMed ID: 10620363 [Abstract] [Full Text] [Related]
3. Do the structures of big ET-1 and big ET-3 adopt a similar overall fold? Consequences for endothelin converting enzyme specificity. Cronin NB, Wallace BA. Biochemistry; 1999 Feb 09; 38(6):1721-6. PubMed ID: 10026250 [Abstract] [Full Text] [Related]
4. The conformation of human big endothelin-1 favours endopeptidase hydrolysis of the TRP21-VAL22 bond. Corder R. Biochem Pharmacol; 1996 Feb 09; 51(3):259-66. PubMed ID: 8573192 [Abstract] [Full Text] [Related]
5. Circular dichroism studies of human big-endothelin-1 (Big ET-1). Wallace BA, Corder R. J Pept Res; 1997 Apr 09; 49(4):331-5. PubMed ID: 9176816 [Abstract] [Full Text] [Related]
6. Solution conformation of human big endothelin-1. Donlan ML, Brown FK, Jeffs PW. J Biomol NMR; 1992 Sep 09; 2(5):407-20. PubMed ID: 1422154 [Abstract] [Full Text] [Related]
7. Big endothelin-1 structure important for specific processing by endothelin-converting enzyme of bovine endothelial cells. Okada K, Arai Y, Hata M, Matsuyama K, Yano M. Eur J Biochem; 1993 Dec 01; 218(2):493-8. PubMed ID: 8269939 [Abstract] [Full Text] [Related]
8. D-Val22 containing human big endothelin-1 analog, [D-Val22]Big ET-1[16-38], inhibits the endothelin converting enzyme. Morita A, Nomizu M, Okitsu M, Horie K, Yokogoshi H, Roller PP. FEBS Lett; 1994 Oct 10; 353(1):84-8. PubMed ID: 7926029 [Abstract] [Full Text] [Related]
9. A fluorogenic assay for endothelin-converting enzyme. von Geldern TW, Holleman WH, Opgenorth TJ. Pept Res; 1991 Oct 10; 4(1):32-5. PubMed ID: 1802235 [Abstract] [Full Text] [Related]
10. Sandwich-type enzyme immunoassay for big endothelin-I in plasma: concentrations in healthy human subjects unaffected by sex or posture. Aubin P, Le Brun G, Moldovan F, Villette JM, Créminon C, Dumas J, Homyrda L, Soliman H, Azizi M, Fiet J. Clin Chem; 1997 Jan 10; 43(1):64-70. PubMed ID: 8990224 [Abstract] [Full Text] [Related]
11. Formation of native disulfide bonds in endothelin-1. Structural evidence for the involvement of a highly specific salt bridge between the prosequence and the endothelin-1 sequence. Aumelas A, Kubo S, Chino N, Chiche L, Forest E, Roumestand C, Kobayashi Y. Biochemistry; 1998 Apr 14; 37(15):5220-30. PubMed ID: 9548753 [Abstract] [Full Text] [Related]
12. The generation of big-endothelin (1-22) (endothelin-valine) from big-endothelin in the soluble fraction of porcine lung. Watanabe T, Yokosawa H. Biochem Int; 1992 Jun 14; 27(1):1-8. PubMed ID: 1627167 [Abstract] [Full Text] [Related]
14. Pharmacological properties of endothelins and big endothelins in ketamine/xylazine or urethane anesthetized rats. Gratton JP, Maurice MC, Rae GA, D'Orléans-Juste P. Am J Hypertens; 1995 Nov 14; 8(11):1121-7. PubMed ID: 8554736 [Abstract] [Full Text] [Related]
15. Contraction to big endothelin-1, big endothelin-2 and big endothelin-3, and endothelin-converting enzyme inhibition in human isolated bronchi. Yap EY, Battistini B, McKay KO. Br J Pharmacol; 2000 Jan 14; 129(1):170-6. PubMed ID: 10694217 [Abstract] [Full Text] [Related]
16. Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro. Maguire JJ, Kuc RE, Davenport AP. Br J Pharmacol; 2001 Nov 14; 134(6):1360-6. PubMed ID: 11704658 [Abstract] [Full Text] [Related]
17. [Phe22]-big endothelin-1[19-37]: a new and potent inhibitor of the endothelin-converting enzyme. Claing A, Neugebauer W, Yano M, Rae GA, D'Orléans-Juste P. J Cardiovasc Pharmacol; 1995 Nov 14; 26 Suppl 3():S72-4. PubMed ID: 8587472 [Abstract] [Full Text] [Related]
18. Processing of proendothelin-1 at the C-terminus of big endothelin-1 is essential for proteolysis by endothelin-converting enzyme-1 in vivo. Kido T, Sawamura T, Hoshikawa H, D'Orléans-Juste P, Denault JB, Leduc R, Kimura J, Masaki T. Eur J Biochem; 1997 Mar 01; 244(2):520-6. PubMed ID: 9119020 [Abstract] [Full Text] [Related]
19. Importance of the C-terminal region of big endothelin-1 for specific conversion by phosphoramidon-sensitive endothelin converting enzyme. Okada K, Takada J, Arai Y, Matsuyama K, Yano M. Biochem Biophys Res Commun; 1991 Oct 31; 180(2):1019-23. PubMed ID: 1953706 [Abstract] [Full Text] [Related]
20. [Phe21]big endothelin-1(18-34) and [Ala31]big endothelin-1(18-34) inhibit the human endothelin-converting enzyme-1 (ECE-1) expressed in CHO-K1 cells in a different fashion. Liu W, Takayanagi R, Ito T, Oba K, Nawata H. FEBS Lett; 1997 Dec 22; 420(1):103-6. PubMed ID: 9450558 [Abstract] [Full Text] [Related] Page: [Next] [New Search]